SCHEMBL4180224

SCHEMBL4180224

Cc1cc(C)c(C(=O)NC(C)C(C)C)c(C)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 7/20 0.53
TAS1R1 Q7RTX1 7/20 0.53
TAS1R2 Q8TE23 7/20 0.53
HPGD P15428 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MCOLN3 Q8TDD5 1/20 0.40
CYP2C9 P11712 2/20 0.40
KMT2A Q03164 1/20 0.40
CYP1A2 P05177 1/20 0.40
TSHR P16473 1/20 0.40
ITGB1 P05556 2/20 0.39
ITGA4 P13612 1/20 0.39
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ALDH1A1 P00352 1/20 0.36
PYGL P06737 1/20 0.36
ITGB3 P05106 1/20 0.36
ITGAV P06756 1/20 0.36
ITGA2B P08514 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21281612 0.84 TAS1R3 (0.51) TAS1R3TAS1R1TAS1R2HPGDNPSR1
SCHEMBL4169220 0.81 TAS1R3 (0.56) TAS1R3TAS1R1TAS1R2HPGDKMT2A
SCHEMBL4175264 0.81 TAS1R3 (0.56) TAS1R3TAS1R1TAS1R2HPGDKMT2A
SCHEMBL4166621 0.81 TAS1R3 (0.56) TAS1R3TAS1R1TAS1R2HPGDKMT2A
SCHEMBL24571262 0.81 TAS1R3 (0.53) TAS1R3TAS1R1TAS1R2ITGB1ITGA4
SCHEMBL4162633 0.78 TSHR (0.63) TAS1R3TAS1R1TAS1R2HPGDCYP2C9
SCHEMBL13927744 0.73 POLB (0.56) TAS1R3TAS1R1TAS1R2HPGDKMT2A
SCHEMBL4170005 0.73 TAS1R3 (0.48) TAS1R3TAS1R1TAS1R2CYP2C9KMT2A
SCHEMBL5800687 0.73 TAS1R3 (0.52) TAS1R3TAS1R1TAS1R2KMT2ALMNA
SCHEMBL2909101 0.73 TAS1R3 (0.47) TAS1R3TAS1R1TAS1R2CYP2C9KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090047379-A1 Benzamide Compounds Useful as High Potency Sweet Taste Enhancers DEWIS MARK L 2009-02-19 US disclosed
US-20090047379-A1 Benzamide Compounds Useful as High Potency Sweet Taste Enhancers DEWIS MARK L 2009-02-19 US disclosed
US-20090047379-A1 Benzamide Compounds Useful as High Potency Sweet Taste Enhancers DEWIS MARK L 2009-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090047379-A1 Benzamide Compounds Useful as High Potency Sweet Taste Enhancers TAS2R10, TAS2R50, TAS2R8 TAS1R3 27/4885TAS1R1 23/4885TAS1R2 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.